Latest Equities News

Ainsworth Game Technology reveals a significant $43.1 million goodwill impairment tied to its North American operations, alongside other one-off losses, tempering its FY25 profit outlook.

Dome Gold Mines has extended its convertible note offer deadline to 31 March 2026, maintaining key terms while adjusting interest payment dates. The move aims to raise up to $7 million through unsecured notes convertible at $0.15 per share.

Maas Group Holdings has agreed to sell its Construction Materials division for up to $1.703 billion, marking a strategic pivot towards digital infrastructure and electrification sectors. The deal, expected to close in late 2026, includes a significant minority investment in AI infrastructure developer Firmus Grid.

Livium Ltd announces a further A$335,000 distribution from its 50% stake in the LieNA joint venture, following receipt of a substantial R&D tax incentive rebate for FY25. The joint venture remains well-funded through FY27, supporting ongoing lithium extraction technology development.

Cyclopharm Limited is accelerating its US market push for Technegas with a A$16 million capital raise following a record 2025 sales performance. The company aims to expand its US installations and advance new clinical applications beyond pulmonary embolism.

Barton Gold Holdings has launched a Definitive Feasibility Study and appointed Bedrock Advisory Partners to steer financing for its Stage 1 operations at Central Gawler Mill, following a significant resource upgrade.

Nova Minerals plans to redomicile to the United States following the loss of its foreign private issuer status, while acquiring full ownership of its Estelle Gold and Critical Minerals Project and appointing a US-based CFO.

Strickland Metals has announced a $55 million institutional placement to fund an expanded drilling program and advance a Pre-Feasibility Study for its Rogozna gold project in Serbia, with major shareholders reaffirming their support.

Apiam Animal Health shareholders have overwhelmingly approved the proposed acquisition by Adamantem Capital-controlled entities, clearing a critical hurdle for the $500 million deal.

OncoSil Medical Ltd has launched an $8 million equity raising to fund the commercial expansion and clinical development of its targeted radiotherapy device for pancreatic cancer, aiming to capitalise on growing European market adoption and upcoming trial catalysts.

Lode Resources is progressing its high-grade silver, antimony, gold, and tin projects in Tasmania and New South Wales, highlighted by robust drilling results and promising metallurgical tests. The company is advancing towards resource estimation and pilot production at Montezuma while expanding exploration across multiple targets.

Theta Gold Mines Limited has released a Revised Feasibility Study for its TGME Gold Mine Project in South Africa, projecting robust economics with a 13.1-year mine life and first gold production slated for early 2027.